These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 6850600

  • 1. Isolation and characterization of subclones of L1210 murine leukemia with different sensitivities to various cytotoxic agents.
    Brouwer M, Smets LA, Jongsma AP.
    Cancer Res; 1983 Jun; 43(6):2884-8. PubMed ID: 6850600
    [Abstract] [Full Text] [Related]

  • 2. Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone.
    Nagase F, Rahman SM, Yokochi T, Kawashima K, Isobe K, Yoshida T, Nagura E, Nakashima I.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6494-9. PubMed ID: 3499976
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y, Saito M, Fukushima H, Takeda Y, Hara T.
    Cancer Res; 1984 Jan 15; 44(1):25-30. PubMed ID: 6197162
    [Abstract] [Full Text] [Related]

  • 4. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC, Schmid FA, Feinberg A, Philips FS, Han J.
    Cancer Res; 1983 Jul 15; 43(7):3074-9. PubMed ID: 6189591
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice.
    Stern AM, Abeles RH, Tashjian AH.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5614-8. PubMed ID: 6498822
    [Abstract] [Full Text] [Related]

  • 6. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
    Smets LA, Homan-Blok J.
    Cancer Res; 1985 Jul 15; 45(7):3113-7. PubMed ID: 4005848
    [Abstract] [Full Text] [Related]

  • 7. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM, Helfman D.
    Cancer Res; 1976 Dec 15; 36(12):4434-8. PubMed ID: 1000492
    [Abstract] [Full Text] [Related]

  • 8. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
    Bhuyan BK, Fraser TJ, Day KJ.
    Cancer Res; 1977 Apr 15; 37(4):1057-63. PubMed ID: 139202
    [Abstract] [Full Text] [Related]

  • 9. Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells.
    Iwasaki H, Liu YP, Nojyo Y, Ueda T, Nakamura T.
    Anticancer Res; 1995 Apr 15; 15(1):133-9. PubMed ID: 7733623
    [Abstract] [Full Text] [Related]

  • 10. Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo.
    Alabaster O, Bunnag B.
    Cancer Res; 1976 Aug 15; 36(8):2744-9. PubMed ID: 1277184
    [Abstract] [Full Text] [Related]

  • 11. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
    Matsushita T, Ryu EK, Hong CI, MacCoss M.
    Cancer Res; 1981 Jul 15; 41(7):2707-13. PubMed ID: 7248939
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro.
    Jackson DV, Bender RA.
    Cancer Res; 1979 Nov 15; 39(11):4346-9. PubMed ID: 291476
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Rauko P, Novotny L, Mego M, Saiko P, Schott H, Szekeres T.
    Neoplasma; 2007 Nov 15; 54(1):68-74. PubMed ID: 17203895
    [Abstract] [Full Text] [Related]

  • 14. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC, Muzyka TG, Fang WD.
    Cancer Res; 1984 Jul 15; 44(7):2929-35. PubMed ID: 6722819
    [Abstract] [Full Text] [Related]

  • 15. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
    Raymakers RA, Slocum HK, Minderman H, Malmberg M, Rustum YM.
    Exp Hematol; 1993 May 15; 21(5):602-7. PubMed ID: 8513859
    [Abstract] [Full Text] [Related]

  • 16. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 15; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 17. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
    Segal-Bendirdjian E, Jacquemin-Sablon A.
    Exp Cell Res; 1995 May 15; 218(1):201-12. PubMed ID: 7537690
    [Abstract] [Full Text] [Related]

  • 19. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS, Ramonas LM.
    J Natl Cancer Inst; 1982 May 15; 68(5):875-80. PubMed ID: 6951095
    [Abstract] [Full Text] [Related]

  • 20. Morphologic differences in leukemic cells (L1210) exposed to 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Iwasaki H, Aoyama H, Ueda T, Uchida M, Nakamura T.
    Anticancer Res; 1992 May 15; 12(3):941-7. PubMed ID: 1622152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.